Webinar: Impact of covid-19 on volunteer interest in clinical trial participation

The COVID-19 pandemic has had a global impact on nearly every facet of life. Aside from the immediate health emergency and burden to society, SARS-CoV-2, COVID-19 has directly impacted or interrupted social, economic and political conventions worldwide. The conduct of clinical research and by extension the continuity of drug development has not been immune to the effects of COVID-19.

This webinar takes an in-depth look at the recent white paper regarding the Impact of COVID-19 on volunteer interest in participating in a clinical trial. In it, Dr Trisha Shamp and Jeff Cosgrove from our Minneapolis site explore the effects of COVID-19 on the sector, identify areas of most concern, and propose the three key areas of influence necessary to address during this pandemic.

Those key areas are Limit Entry, Limit Spread, Limit Myth.